Your browser doesn't support javascript.
loading
Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.
Dokras, Anuja; Playford, Martin; Kris-Etherton, Penny M; Kunselman, Allen R; Stetter, Christy M; Williams, Nancy I; Gnatuk, Carol L; Estes, Stephanie J; Sarwer, David B; Allison, Kelly C; Coutifaris, Christos; Mehta, Nehal; Legro, Richard S.
Afiliação
  • Dokras A; The Obstetrics and Gynecology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Playford M; Section of Inflammation and Cardiometabolic Disease, National Heart, Lung and Blood Institute, Bethesda, MA, USA.
  • Kris-Etherton PM; Department of Nutritional Sciences, Penn State College of Health and Human Development, University Park, Philadelphia, PA, USA.
  • Kunselman AR; Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
  • Stetter CM; Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
  • Williams NI; Department of Kinesiology, Penn State College of Health and Human Development, University Park, Philadelphia, PA, USA.
  • Gnatuk CL; Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, PA, USA.
  • Estes SJ; Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, PA, USA.
  • Sarwer DB; Department of Psychiatry, Temple University, Philadelphia, PA, USA.
  • Allison KC; Department of Social and Behavioral Science, Center for Obesity Research and Education, College of Public Health, Temple University, Philadelphia, PA, USA.
  • Coutifaris C; Department of Psychiatry, Temple University, Philadelphia, PA, USA.
  • Mehta N; The Obstetrics and Gynecology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Legro RS; Section of Inflammation and Cardiometabolic Disease, National Heart, Lung and Blood Institute, Bethesda, MA, USA.
Clin Endocrinol (Oxf) ; 86(5): 739-746, 2017 May.
Article em En | MEDLINE | ID: mdl-28199736
OBJECTIVE: To study the effects of oral contraceptive pills (OCP), the first-line treatment for PCOS, on high-density lipoprotein cholesterol (HDL-C) function (reverse cholesterol efflux capacity) and lipoprotein particles measured using nuclear magnetic resonance spectroscopy in obese women. DESIGN: Secondary analysis of a randomized controlled trial (OWL-PCOS) of OCP or Lifestyle (intensive Lifestyle modification) or Combined (OCP + Lifestyle) treatment groups for 16 weeks. PATIENTS: Eighty-seven overweight/obese women with PCOS at two academic centres. MEASUREMENTS: Change in HDL-C efflux capacity and lipoprotein particles. RESULTS: High-density lipoprotein cholesterol efflux capacity increased significantly at 16 weeks in the OCP group [0·11; 95% confidence interval (CI) 0·03, 0·18, P = 0·008] but not in the Lifestyle (P = 0·39) or Combined group (P = 0·18). After adjusting for HDL-C and TG levels, there was significant mean change in efflux in the Combined group (0·09; 95% CI 0·01, 0·15; P = 0·01). Change in HDL-C efflux correlated inversely with change in serum testosterone (rs = -0·21; P = 0·05). In contrast, OCP use induced an atherogenic low-density lipoprotein cholesterol (LDL-C) profile with increase in small (P = 0·006) and large LDL-particles (P = 0·002). Change in small LDL-particles correlated with change in serum testosterone (rs = -0·31, P = 0·009) and insulin sensitivity index (ISI; rs = -0·31, P = 0·02). Both Lifestyle and Combined groups did not show significant changes in the atherogenic LDL particles. CONCLUSIONS: Oral contraceptive pills use is associated with improved HDL-C function and a concomitant atherogenic LDL-C profile. Combination of a Lifestyle program with OCP use improved HDL-C function and mitigated adverse effects of OCP on lipoproteins. Our study provides evidence for use of OCP in overweight/obese women with PCOS when combined with Lifestyle changes.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Redução de Peso / Anticoncepcionais Orais / Comportamento de Redução do Risco / Sobrepeso / HDL-Colesterol / LDL-Colesterol Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Female / Humans Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Redução de Peso / Anticoncepcionais Orais / Comportamento de Redução do Risco / Sobrepeso / HDL-Colesterol / LDL-Colesterol Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Female / Humans Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos